Catalyst Wire Dossier Catalyst Wire Dossier

vafidemstat

vafidemstat · Oryzon Genomics S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for vafidemstat, covering 2023-11-28 to 2023-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population [Phase 2]

See pricing